7242 J. Am. Chem. Soc., Vol. 122, No. 30, 2000
Naka et al.
brine. The organic layer was dried (Na2SO4) and concentrated in vacuo.
The residue was purified by a silica gel column, eluted with hexane/
AcOEt (7:1), to give 19 (93 mg, 41% as a colorless oil): FAB-LRMS
55.59, 54.34. Anal. Calcd for C19H19N4O6SCl: C, 48.87; H, 4.10; N,
12.00. Found: C, 48.54; H, 4.10; N, 11.76.
9-(4-Thio-â-D-ribofuranosyl)adenine (27). A solution of 26 (37 mg,
0.08 mmol) in ethanolic ammonia (saturated at 0 °C, 5 mL) was heated
for 24 h at 100 °C in a steel container. The solvent was removed in
vacuo, and the residue was purified by a silica gel column, eluted with
25% MeOH in CHCl3, to give 27 (18 mg, 83%, crystallized from
MeOH-H2O): mp 254-256 °C (lit.15 mp 246-248 °C); FAB-LRMS
1
m/z 555 (M+ - OAc, 6.0%); H NMR (270 MHz, CDCl3) δ 7.86 (d,
0.5 H, J ) 8.6 Hz), 7.82 (d, 0.5 H, J ) 9.2 Hz), 6.48 (m, 2 H), 5.77
(s, 0.5 H), 5.62 (d, 0.5 H, J ) 3.3 Hz), 5.57 (m, 0.5 H), 4.63 (dd, 0.5
H, J ) 3.3, 9.8 Hz), 4.58 (m, 1H), 4.15-4.06 (m, 1.5 H), 3.88, 3.87,
3.86, 3.85 (each s, each 1.5 H), 3.66 (m, 0.5 H), 3.26 (dd, 0.5 H, J )
9.2, 10.6 Hz), 3.09 (dd, 0.5 H, 6.6, 9.2 Hz), 2.07, 2.05 (each s, each
1.5 H), 1.13-0.98 (m, 28 H); 13C NMR (125 MHz, CDCl3) δ 169.33,
169.22, 164.59, 164.53, 164.15, 161.75, 161.72, 133.97, 133.74, 111.87,
111.74, 104.66, 104.36, 99.01, 98.82, 96.97, 78.92, 77.58, 74.90, 72.41,
61.19, 59.26, 55.97, 55.86, 55.49, 49.77, 30.44, 21.90, 20.86, 17.45,
17.32, 17.29, 17.25, 17.22, 17.19, 17.16, 17.03, 13.48, 13.36, 13.07,
13.00, 12.77, 12.72, 12.46.
1
m/z 285 (MH+, 33.3%); H NMR (400 MHz, DMSO-d6) δ 8.42, 8.12
(each s, each 1 H, H-2 and 8), 7.27 (br s, 2 H, NH2), 6.59 (d, 1 H,
H-1′, J1′,2′ ) 6.6 Hz), 5.57 (d, 1 H, 2′-OH, J2′OH,2′ ) 6.1 Hz), 5.35 (d,
1 H, 3′-OH, J3′-OH,3′ ) 4.6 Hz), 5.23 (t, 1 H, 5′-OH, J5′-OH,5′ ) 5.6
Hz), 4.63 (ddd, 1 H, H-2′, J2′,2′-OH ) 6.1, J2′,1′ ) 6.6, J2′,3′ ) 3.4 Hz),
4.17 (ddd, 1 H, H-3′, J3′,3′-OH ) 4.6, J3′,2′ ) 3.4, J3′,4′ ) 3.4 Hz), 3.76
(ddd, 1 H, H-5′a, J5′a,5′-OH ) 5.6, J5′a,4′ ) 6.6, J5′a,5′b ) 11.2 Hz), 3.59
(ddd, 1 H, H-5′b, J5′b,5′-OH ) 5.6, J5′b,4′ ) 5.9, J5′b,5′a ) 11.2 Hz), 3.29
(ddd, 1 H, H-4′, J4′,3′ ) 3.4, J4′,5′a ) 6.6, J4′,5′b ) 5.9 Hz). Anal. Calcd
for C10H13N5O3S‚0.6H2O: C, 40.84; H, 4.87; N, 23.81. Found: C, 41.01;
H, 4.86; N, 23.45.
6-Chloro-9-[2-O-(2,4-dimethoxybenzoyl)-3,5-O-(1,1,3,3-tetraiso-
propyldisiloxane-1,3-diyl)-4-thio-â-D-ribofuranosyl]-9H-purine (25).
To a suspension of 6-chloropurine (70 mg, 0.46 mmol) in a mixture of
dry CH3CN (2 mL) and 1,2-dichloroethane (1 mL) were added
triethylamine (65 µL, 0.46 mmol) and TMSOTf (180 µL, 0.93 mmol),
and the mixture was stirred at room temperature until the solution was
clear. The resulting solution was added to a solution of 10 (67 mg,
0.12 mmol, R/S ) >16:1) in dry 1,2-dichloroethane (1 mL) dropwise
over 15 min via a cannula. An additional amount of triethylamine (65
µL, 0.46 mmol) in dry 1,2-dichloroethane (0.5 mL) was added dropwise
to the reaction mixture to initiate the Pummerer reaction. After being
stirred at room temperature for 5 min, the reaction mixture was heated
at 83 °C for 24 h. The reaction was quenched by addition of ice, and
the reaction mixture was partitioned between AcOEt and H2O. The
separated organic layer was washed with saturated aqueous NaHCO3
(three times), followed by brine. The organic layer was dried (Na2-
SO4) and concentrated in vacuo. The residue was purified by a silica
gel column, eluted with hexane/AcOEt (5:1-1:1), to give 25 (53 mg,
65% as a yellow solid): FAB-LRMS m/z 709 (MH+, 1.0%); 1H NMR
(400 MHz, CDCl3) δ 8.76, 8.59 (each s, each 1 H, H-2 and 8), 7.93 (d,
1 H, Ar, J ) 8.8 Hz), 5.96 (m, 2 H, Ar), 6.07 (s, 1 H, H-1′), 5.84 (d,
1 H, H-2′, J2′,3′ ) 3.9 Hz), 4.96 (dd, 1 H, H-3′, J3′,2′ ) 3.9, J3′,4′ ) 9.8
Hz), 4.56 (dd, 1 H, H-5′a, J5′a,4′ ) 2.9, J5′a,5′b ) 12.9 Hz), 4.12 (d, 1 H,
H-5′b, J5′b,5′a ) 12.9 Hz), 3.90, 3.88 (each s, each 3 H, MeO × 2),
3.86 (dd, 1 H, H-4′, J4′,3′ ) 9.8, J4′,5′a ) 2.9 Hz), 1.16-0.89 (m, 28 H,
TIPDS); 13C NMR (125 MHz, CDCl3) δ 164.64, 163.59, 161.69,
152.07, 151.18, 151.10, 144.24, 134.02, 132.17, 111.24, 104.63, 98.88,
77.87, 72.22, 60.65, 58.10, 55.98, 55.56, 51.36, 17.52, 17.43, 17.12,
17.08, 16.98, 13.36, 13.24, 13.08, 12.65. Anal. Calcd for C31H46N4O7-
SSi2Cl: C, 52.49; H, 6.39; N, 7.90. Found: C, 52.38; H, 6.40; N, 7.56.
1H NMR data for 6-chloro-7-[2-O-(2,4-dimethoxybenzoyl)-3,5-O-
(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-4-thio-â-D-ribofuranosyl]-
2-Amino-6-chloro-9-[2-O-(2,4-dimethoxybenzoyl)-3,5-O-(1,1,3,3-
tetraisopropyldisiloxane-1,3-diyl)-4-thio-â-D-ribofuranosyl]-9H-pu-
rine (28). In the same manner as described for 25, the Pummerer
reaction of 10 (179 mg, 0.31 mmol, R/S ) >16:1) with 2-amino-6-
chloropurine (106 mg, 0.62 mmol) gave 28 (127 mg, 56% as a white
solid): FAB-LRMS m/z 724 (MH+, 0.3%); 1H NMR (500 MHz, CDCl3)
δ 8.25 (s, 1 H, H-8), 7.87 (d, 1 H, Ar, J ) 8.4 Hz), 6.49 (m, 2 H, Ar),
5.84 (s, 1 H, H-1′), 5.77 (d, 1 H, H-2′, J2′, 3′ ) 3.6 Hz), 5.29 (br s, 2 H,
NH2), 4.71 (dd, 1 H, H-3′, J3′,2′ ) 3.6, J3′,4′ ) 9.5 Hz), 4.17 (dd, 1 H,
H-5′a, J5′a,4′ ) 2.9, J5′a,5′b ) 12.6 Hz), 4.08 (d, 1 H, H-5′b, J5′b,5′a
)
12.6 Hz), 3.87, 3.84 (each s, each 3 H, MeO × 2), 3.79 (m, 1 H, H-4′),
1.13-0.86 (m, 28 H, TIPDS); 13C NMR (125 MHz, CDCl3) δ 164.70,
163.55, 161.72, 159.19, 153.27, 151.45, 140.79, 134.01, 125.57, 111.52,
104.73, 99.00, 77.83, 72.39, 59.59, 58.26, 55.99, 55.52, 50.93, 17.45,
17.34, 17.04, 17.02, 16.87, 13.35, 13.18, 13.05, 12.59. Anal. Calcd for
C31H46N5O7SSi2Cl: C, 51.33; H, 6.53; N, 9.65. Found: C, 51.45; H,
6.52; N, 9.23.
2-Amino-6-chloro-9-[2-O-(2,4-dimethoxybenzoyl)-4-thio-â-D-ri-
bofuranosyl]-9H-purine (29). In the same manner as described for
26, treatment of 28 (127 mg, 0.18 mmol) with TBAF (1 M in THF,
350 µL, 0.35 mmol) gave 29 (84 mg, 99% as a white solid): FAB-
LRMS m/z 482 (MH+, 2.5%); 1H NMR (400 MHz, DMSO-d6) δ 8.55
(s, 1 H, H-8), 7.66 (d, 1 H, Ar, J ) 9.3 Hz), 7.04 (br s, 2 H, NH2),
6.54 (m, 2 H, Ar), 6.14 (d, 1 H, H-1′, J1′,2′ ) 7.3 Hz), 5.75 (m, 2 H,
H-2′ and 3′-OH), 5.32 (br s, 1 H, 5′-OH), 4.57 (m, 1 H, H-3′), 3.86
(m, 1 H, H-5′a), 3.79 (s, 3 H, MeO), 3.72 (m, 1 H, H-5′b), 3.64 (s, 3
H, MeO), 3.43 (m, 1 H, H-4′); 13C NMR (100 MHz, DMSO-d6) δ
164.17, 163.36, 160.90, 159.70, 153.99, 149.50, 141.63, 133.40, 123.24,
110.73, 105.33, 98.74, 78.37, 71.22, 62.95, 58.67, 55.69, 55.64, 54.32.
Anal. Calcd for C19H20N5O6SCl‚0.5H2O: C, 46.49; H, 4.31; N, 14.27.
Found: C, 46.64; H, 4.19; N, 14.11.
1
9H-purine (24): H NMR (270 MHz, CDCl3) δ 9.11, 8.88 (each s,
each 1 H, H-2 and 8), 7.82 (d, 1 H, Ar, J ) 8.4 Hz), 6.45 (m, 2 H, Ar),
6.41 (s, 1 H, H-1′), 5.83 (d, 1 H, H-2′, J2′,3′ ) 3.2 Hz), 4.60 (dd, 1 H,
H-3′, J3′,2′ ) 3.2, J3′,4′ ) 9.2 Hz), 4.19 (dd, 1 H, H-5′a, J5′a,4′ ) 3.2,
J5′a,5′b ) 13.0 Hz), 4.10 (d, 1 H, H-5′b, J5′b,5′a ) 13.0 Hz), 3.86, 3.84
(each s, each 3 H, MeO × 2), 3.82 (m, 1 H, H-4′), 1.17-0.87 (m, 28
H, TIPDS).
9-(4-Thio-â-D-ribofuranosyl)guanine (30). A solution of 29 (80
mg, 0.17 mmol) in MeOH (10 mL) containing 2-mercaptoethanol (47
µL, 0.66 mmol) and NaOMe (28% solution, 130 µL) was heated under
reflux for 24 h. The reaction mixture was neutralized with 1 N HCl,
and the solution was concentrated in vacuo. The residue was dissolved
in H2O, and the aqueous layer was washed with AcOEt. The aqueous
layer was concentrated in vacuo, and the residue was crystallized from
H2O to give 30 (28 mg, 55% as pale brown crystals): mp 240 °C dec;
FAB-LRMS m/z 300 (MH+, 8.3%); 1H NMR (400 MHz, DMSO-d6) δ
10.64 (br s, 1 H, NH), 8.02 (s, 1 H, H-8), 6.50 (br s, 2 H, NH2), 5.65
(d, 1 H, H-1′, J1′,2′ ) 6.8 Hz), 5.48 (d, 1 H, 2′-OH, J2′OH,2′ ) 5.6 Hz),
5.28 (m, 1 H, 3′-OH), 5.15 (t, 1 H, 5′-OH, J5′-OH,5′ ) 5.4 Hz), 4.46
(ddd, 1 H, H-2′, J2′,2′-OH ) 5.6, J2′,1′ ) 6.8, J2′,3′ ) 3.4 Hz), 4.15 (m, 1
6-Chloro-9-[2-O-(2,4-dimethoxybenzoyl)-4-thio-â-D-ribofurano-
syl]-9H-purine (26). To a solution of 25 (52 mg, 0.07 mmol) in THF
(2 mL) containing AcOH (9 µL, 0.15 mmol) was added TBAF (1 M
in THF, 150 µL, 0.15 mmol). The mixture was stirred at room
temperature for 10 min. The solvent was removed in vacuo, and the
residue was purified by a silica gel column, eluted with acetone, to
give 26 (34 mg, 99% as a white solid): FAB-LRMS m/z 467 (MH+,
1
22.7%); H NMR (400 MHz, CDCl3) δ 8.81, 8.34 (each s, each 1 H,
H-2 and 8), 7.73 (d, 1 H, Ar, J ) 8.6 Hz), 6.50 (m, 2 H, Ar), 6.27 (d,
1 H, H-1′, J1′,2′ ) 6.3 Hz), 6.23 (dd, 1 H, H-2′, J2′,1′ ) 6.3, J2′,3′ ) 9.8
Hz), 4.81 (dd, 1 H, H-3′, J3′,2′ ) 9.8, J3′,4′ ) 3.7 Hz), 4.27 (m, 1 H,
5′-OH), 4.15 (m, 1 H, H-5′a, J5′a,4′ ) 3.2, J5′a,5′b ) 12.0 Hz), 4.01 (m,
1 H, H-5′b, J5′b,4′ ) 2.9, J5′b,5′a ) 12.0 Hz), 3.88, 3.85 (each s, each 3
H, H-3′), 3.72 (ddd, 1 H, H-5′a, J5′a,5′-OH ) 5.4, J5′a,4′ ) 7.1, J5′a,5′b
11.4 Hz), 3.53 (ddd, 1 H, H-5′b, J5′b,5′-OH ) 5.4, J5′b,4′ ) 5.9, J5′b,5′a
)
)
11.4 Hz), 3.24 (m, 1 H, H-4′); 13C NMR (100 MHz, DMSO-d6) δ
156.61, 153.39, 151.53, 135.84, 116.40, 76.99, 73.03, 63.18, 60.16,
52.96. Anal. Calcd for C10H13N5O4S‚0.5H2O: C, 38.90; H, 4.58; N,
22.71. Found: C, 39.28; H, 4.47; N, 22.82.
H, MeO × 2), 3.79 (ddd, 1 H, H-4′, J4′,3′ ) 3.7, J4′,5′a ) 3.2, J4′,5′b
)
2.9 Hz), 3.20 (d, 1 H, 3′-OH, J3′-OH,3′ ) 3.2 Hz); 13C NMR (100 MHz,
CDCl3) δ 165.00, 164.40, 160.80, 151.69, 151.44, 150.88, 144.95,
134.37, 132.86, 110.34, 105.07, 99.01, 79.67, 77.12, 75.30, 63.53, 56.06,